InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0000950170-25-022203 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-02-18 2025-02-14 SLDB Brooks Gabriel Chief Medical Off S - Sale+OE $3.96 -3,256 22.8K -12% -$12.9K
DT 2025-02-18 2025-02-13 SLDB Brooks Gabriel Chief Medical Off M - OptEx — +10.9K 26.1K +72% —
DT 2025-02-18 2025-02-13 SLDB Brooks Gabriel Chief Medical Off M - OptEx $0.00 -10.9K 32.8K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-14 S D 3,256 $3.96 22,812 D — — (F2) This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
2 Common Common Stock 2025-02-13 M A 10,937 — 26,068 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
3 Derivative Restricted Stock Units 2025-02-13 M D 10,937 $0.00 32,813 D — · — to — 10,937 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). (F3) The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.